Skinvisible Inc
Skinvisible, Inc. focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company's flagship product includes I… Read more
Skinvisible Inc (SKVI) - Total Liabilities
Latest total liabilities as of September 2025: $10.14 Million USD
Based on the latest financial reports, Skinvisible Inc (SKVI) has total liabilities worth $10.14 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Skinvisible Inc - Total Liabilities Trend (2000–2024)
This chart illustrates how Skinvisible Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Skinvisible Inc Competitors by Total Liabilities
The table below lists competitors of Skinvisible Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
China Bozza Development Holdings Limited
PINK:CHBOF
|
USA | $158.70 Million |
|
Glassbox Ltd
TA:GLBX
|
Israel | ILA30.08 Million |
|
Shield On Service Tbk PT
JK:SOSS
|
Indonesia | Rp206.03 Billion |
|
AcSiP Technology Corp.
TWO:6403
|
Taiwan | NT$67.47 Million |
|
OCB Bhd
KLSE:5533
|
Malaysia | RM77.19 Million |
|
HESS (AHC.SG)
STU:AHC
|
Germany | €14.63 Billion |
|
Auriant Mining AB (publ)
ST:AUR
|
Sweden | Skr68.99 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Skinvisible Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 75.87 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Skinvisible Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Skinvisible Inc (2000–2024)
The table below shows the annual total liabilities of Skinvisible Inc from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $9.40 Million | +2.38% |
| 2023-12-31 | $9.19 Million | +33.37% |
| 2022-12-31 | $6.89 Million | +22.05% |
| 2021-12-31 | $5.64 Million | +21.22% |
| 2020-12-31 | $4.66 Million | +45.97% |
| 2019-12-31 | $3.19 Million | -35.44% |
| 2018-12-31 | $4.94 Million | -33.17% |
| 2017-12-31 | $7.39 Million | +14.64% |
| 2016-12-31 | $6.45 Million | +6.35% |
| 2015-12-31 | $6.06 Million | +21.33% |
| 2014-12-31 | $5.00 Million | +38.38% |
| 2013-12-31 | $3.61 Million | +52.23% |
| 2012-12-31 | $2.37 Million | +127.86% |
| 2011-12-31 | $1.04 Million | -20.23% |
| 2010-12-31 | $1.30 Million | +19.29% |
| 2009-12-31 | $1.09 Million | +64.51% |
| 2008-12-31 | $665.00K | -37.85% |
| 2007-12-31 | $1.07 Million | -6.96% |
| 2006-12-31 | $1.15 Million | -2.95% |
| 2005-12-31 | $1.19 Million | +22.16% |
| 2004-12-31 | $970.00K | +35.10% |
| 2003-12-31 | $718.00K | +17.32% |
| 2002-12-31 | $612.00K | -8.25% |
| 2001-12-31 | $667.00K | +65.51% |
| 2000-12-31 | $403.00K | -- |